MATINAS BIOPHARMA HOLDINGS, INC. Debt Securities, Available-for-sale
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Debt Securities, Available-for-sale of $500.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-04-15
- 2024-09-30: Debt Securities, Available-for-sale $500.00K.
- 2024-06-30: Debt Securities, Available-for-sale $10.10M.
- 2024-03-31: Debt Securities, Available-for-sale $7.04M.
- 2023-12-31: Debt Securities, Available-for-sale $8.97M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2024-09-30 | $500.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.10M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $7.04M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.97M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $11.81M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $12.77M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $19.12M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $21.93M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $21.88K 10-Q · filed 2022-11-02 | |
| 2022-03-31 | $28.10M 10-Q · filed 2022-08-11 | $24.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $28.59K 10-K · filed 2023-03-15 | $28.59M 10-K · filed 2022-03-08 |
| 2021-09-30 | $28.91M 10-Q · filed 2021-11-08 | |
| 2021-03-31 | $136.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $46.25M 10-K/A · filed 2022-03-11 | $228.00K 10-Q · filed 2021-05-10 |
| 2020-03-31 | $522.00K 10-Q · filed 2021-05-10 | $522.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |